Evaluate EGFR Mutation Status and Impact Factors in North China

ying cheng

Status: Completed

Conditions: Non-Small Cell Lung Cancer

Treatments: Other: Non interventional study

Study type: Observational

Funder types: Other

Identifiers

NCT02620657

11224 (Registry Identifier)

Details and patient eligibility

About

Approximately 3000 advanced NSCLC patients, who fulfil the inclusion/exclusion criteria, will be recruited by 30 sites in North China.

Full description

Approximately 3000 advanced NSCLC patients will be recruited , and the medical information of recruited patients must be recorded in the hospital electronic system from Jan 1st 2014 to Dec 31st 2014 .The study will focus on the EGFR testing rate in adenocarcinoma patients，so the collecting data for non-adenocarcinoma patients will be controlled in less than 10% for each site.

Enrollment: 2,809 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histological or cytological confirmed NSCLC;
• Patients were diagnosed with advanced NSCLC from Jan 1st 2014 to Dec 31st 2014;
• Researchers should collect the records of consecutive NSCLC patients in each site.

Exclusion criteria

• Any patients without NSCLC diagnosis;
• Any patients which were diagnosed with advanced NSCLC before Jan 1st 2014 or after Dec 31st 2014.

Trial design

2,809 participants in 1 patient group

Non interventional study

Description:

The patients with advanced NSCLC who have the medical records from Jan 1st 2014 to Dec 31st 2014 will be recruited .

Treatment:

Other: Non interventional study